Diazepam Injection Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Manufacturer
Mechanism of Action
Diazepam Injection Indications
Indications
Diazepam Injection Dosage and Administration
Adult
Children
Diazepam Injection Contraindications
Contraindications
Diazepam Injection Boxed Warnings
Boxed Warning
Diazepam Injection Warnings/Precautions
Warnings/Precautions
Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.
Diazepam Injection Pharmacokinetics
See Literature
Diazepam Injection Interactions
Interactions
Diazepam Injection Adverse Reactions
Adverse Reactions
Diazepam Injection Clinical Trials
See Literature
Diazepam Injection Note
Not Applicable
Diazepam Injection Patient Counseling
See Literature
Diazepam Injection Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Manufacturer
Mechanism of Action
Diazepam Injection Indications
Indications
Diazepam Injection Dosage and Administration
Adult
Children
Diazepam Injection Contraindications
Contraindications
Diazepam Injection Boxed Warnings
Boxed Warning
Diazepam Injection Warnings/Precautions
Warnings/Precautions
Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.
Diazepam Injection Pharmacokinetics
Absorption
Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.
Distribution
Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.
Elimination
Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).
Diazepam Injection Interactions
Interactions
Diazepam Injection Adverse Reactions
Adverse Reactions
Diazepam Injection Clinical Trials
See Literature
Diazepam Injection Note
Not Applicable
Diazepam Injection Patient Counseling
See Literature
Diazepam Injection Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Manufacturer
Mechanism of Action
Diazepam Injection Indications
Indications
Diazepam Injection Dosage and Administration
Adult
Children
Diazepam Injection Contraindications
Contraindications
Diazepam Injection Boxed Warnings
Boxed Warning
Diazepam Injection Warnings/Precautions
Warnings/Precautions
Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.
Diazepam Injection Pharmacokinetics
See Literature
Diazepam Injection Interactions
Interactions
Diazepam Injection Adverse Reactions
Adverse Reactions
Diazepam Injection Clinical Trials
See Literature
Diazepam Injection Note
Not Applicable
Diazepam Injection Patient Counseling
See Literature
Diazepam Injection Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Manufacturer
Mechanism of Action
Diazepam Injection Indications
Indications
Diazepam Injection Dosage and Administration
Adult
Children
Diazepam Injection Contraindications
Contraindications
Diazepam Injection Boxed Warnings
Boxed Warning
Diazepam Injection Warnings/Precautions
Warnings/Precautions
Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.
Diazepam Injection Pharmacokinetics
Absorption
Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.
Distribution
Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.
Elimination
Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).
Diazepam Injection Interactions
Interactions
Diazepam Injection Adverse Reactions
Adverse Reactions
Diazepam Injection Clinical Trials
See Literature
Diazepam Injection Note
Not Applicable
Diazepam Injection Patient Counseling
See Literature